Phenotype measure

ID, description, units MPD:37823   TG   triglycerides (plasma TG, 4h fast)   [mg/dL]
Data set, strains RIKEN-EAD2   wild-derived RBRC   26 strains     sex: both     age: 8wks
Procedure lipid profile
Availability note:Individual animal data were not submitted. Some functionality not available.
Ontology mappings


  STRAIN COMPARISON PLOT
width:   ×  height:  pixels

RIKEN-EAD2 - triglycerides (plasma TG, 4h fast)



  MEASURE SUMMARY
Measure Summary FemaleMale
Number of strains tested26 strains20 strains
Mean of the strain means52.8   mg/dL 51.6   mg/dL
Median of the strain means52.1   mg/dL 45.8   mg/dL
SD of the strain means± 15.4 ± 14.8
Coefficient of variation (CV)0.291 0.287
Min–max range of strain means26.0   –   92.5   mg/dL 36.1   –   99.4   mg/dL
Mean sample size per strain11.7   mice 12.0   mice




  STRAIN MEANS (UNADJUSTED)
Strain Sex Mean SD N mice SEM CV Min, Max Z score
AIZ/StmRbrc f 64.8 3.9   16 0.975 0.0602 None, None 0.78
AKT/TuaRbrc f 46.0 4.38   17 1.06 0.0953 None, None -0.45
AKT/TuaRbrc m 61.7 7.06   16 1.76 0.114 None, None 0.69
AST/TuaRbrc f 61.6 6.61   17 1.6 0.107 None, None 0.57
AST/TuaRbrc m 62.1 6.02   15 1.55 0.0969 None, None 0.71
BFM/2MsRbrc f 71.2 4.34   12 1.25 0.0609 None, None 1.2
BLG2/MsRbrc f 43.5 4.05   15 1.05 0.0931 None, None -0.61
BLG2/MsRbrc m 44.2 3.35   14 0.894 0.0757 None, None -0.5
CHD/MsRbrc f 69.5 4.2   11 1.26 0.0604 None, None 1.08
CHD/MsRbrc m 60.4 4.15   8 1.47 0.0687 None, None 0.6
HMI/MsRbrc f 29.8 3.58   10 1.13 0.12 None, None -1.5
HMI/MsRbrc m 42.9 4.0   11 1.21 0.0932 None, None -0.59
Irk/TuaRbrc f 38.9 3.74   16 0.935 0.0962 None, None -0.91
Irk/TuaRbrc m 38.2 3.81   17 0.924 0.0997 None, None -0.9
Jil/OdaRbrc f 59.8 5.21   17 1.26 0.0871 None, None 0.45
Jil/OdaRbrc m 54.9 4.46   16 1.12 0.0813 None, None 0.23
KJR/MsRbrc f 67.0 6.43   8 2.27 0.096 None, None 0.92
KJR/MsRbrc m 46.5 4.42   12 1.27 0.095 None, None -0.34
KOR1/StmRbrc f 45.1 4.34   10 1.37 0.0961 None, None -0.5
KOR1/StmRbrc m 63.1 4.89   8 1.73 0.0775 None, None 0.78
KOR5/StmRbrc f 56.8 3.33   8 1.18 0.0587 None, None 0.26
KOR5/StmRbrc m 66.7 4.79   17 1.16 0.0717 None, None 1.03
KOR7/StmRbrc f 92.5 6.78   15 1.75 0.0733 None, None 2.58
MAE/StmRbrc f 54.9 5.47   8 1.93 0.0996 None, None 0.13
MAE/StmRbrc m 36.1 2.81   11 0.849 0.078 None, None -1.05
MBT/PasRbrc f 33.2 3.18   8 1.12 0.0957 None, None -1.28
MBT/PasRbrc m 40.4 3.73   17 0.904 0.0923 None, None -0.75
MOM/NgaRbrc f 55.4 4.22   8 1.49 0.0762 None, None 0.17
MSM/MsRbrc f 79.6 4.88   13 1.35 0.0613 None, None 1.74
MYS/MzRbrc f 56.1 3.77   10 1.19 0.0672 None, None 0.21
MYS/MzRbrc m 43.5 4.07   8 1.44 0.0937 None, None -0.55
Okh/TuaRbrc f 43.4 3.49   16 0.873 0.0805 None, None -0.62
PGN2/MsRbrc f 26.0 3.15   10 0.995 0.121 None, None -1.75
PGN2/MsRbrc m 36.2 3.07   11 0.925 0.0847 None, None -1.04
PWK/RpRbrc f 49.4 3.96   8 1.4 0.0802 None, None -0.22
PWK/RpRbrc m 54.1 4.32   9 1.44 0.0799 None, None 0.17
SPI/TuaRbrc f 44.9 3.71   16 0.929 0.0827 None, None -0.52
SPI/TuaRbrc m 44.6 3.33   16 0.833 0.0747 None, None -0.47
SPR2/Rbrc f 46.2 5.34   8 1.89 0.116 None, None -0.43
STM1/StmRbrc f 41.5 4.17   6 1.7 0.101 None, None -0.74
STM1/StmRbrc m 49.1 4.35   9 1.45 0.0885 None, None -0.17
SWN/MsRbrc f 55.0 4.43   10 1.4 0.0805 None, None 0.14
SWN/MsRbrc m 41.9 3.61   9 1.2 0.0861 None, None -0.65
WMP/PasRbrc f 41.9 2.94   11 0.886 0.0701 None, None -0.71
WMP/PasRbrc m 45.1 3.66   8 1.29 0.0812 None, None -0.44
ZBN/MsRbrc m 99.4 5.37   9 1.79 0.054 None, None 3.24